Connor, Clark & Lunn Investment Management (CC&L)
NVAX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Novavax NVAX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44,260
Closed -$559K – 1565
2024
Q3 		$559K Sell
44,260
-97,515
-69% -$1.26M ﹤0.01% 1072
2024
Q2 		$1.79M Buy
+141,775
New +$1.43M 0.01% 684
2022
Q2 		– Sell
-259,383
Closed -$19.1M – 1157
2022
Q1 		$19.1M Buy
259,383
+75,823
+41% +$6.76M 0.09% 160
2021
Q4 		$26.3M Sell
183,560
-1,206
-0.7% -$207K 0.13% 137
2021
Q3 		$38.3M Buy
184,766
+117,238
+174% +$25.8M 0.2% 99
2021
Q2 		$14.3M Buy
67,528
+31,931
+90% +$5.85M 0.07% 198
2021
Q1 		$6.45M Sell
35,597
-26,493
-43% -$5.28M 0.04% 306
2020
Q4 		$6.92M Sell
62,090
-3,952
-6% -$420K 0.04% 272
2020
Q3 		$7.16M Buy
66,042
+21,498
+48% +$2.62M 0.05% 246
2020
Q2 		$3.71M Buy
+44,544
New +$1.7M 0.03% 351
2018
Q4 		– Sell
-7,778
Closed -$292K – 1017
2018
Q3 		$292K Buy
7,778
+5,713
+277% +$161K ﹤0.01% 790
2018
Q2 		$55K Buy
+2,065
New +$69.8K ﹤0.01% 1011
2015
Q2 		– Sell
-4,045
Closed -$669K – 650
2015
Q1 		$669K Buy
4,045
+1,980
+96% +$322K 0.01% 361
2014
Q4 		$245K Buy
+2,065
New +$216K ﹤0.01% 498
2014
Q2 		– Sell
-16,442
Closed -$1.64M – 605
2014
Q1 		$1.64M Buy
+16,442
New +$1.84M 0.01% 300

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NVAX Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Novavax (NVAX) in Q4 2024, closing a stake of 44,260 shares — an estimated $559K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NVAX in Q1 2014 and held it in 15 quarters. The position peaked at $38.3M in Q3 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 44,260 Novavax shares in Q4 2024, an estimated $559K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Novavax in Q1 2014 and held it in 15 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Novavax position peaked at $38.3M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.